Voyager Therapeutics to Present at the Chardan Genetic Medicines Conference
25 Septiembre 2023 - 6:00AM
Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company
dedicated to breaking through barriers in gene therapy and
neurology, today announced that Chief Executive Officer Alfred W.
Sandrock, Jr., M.D., Ph.D., will present at the Chardan 7th Annual
Genetic Medicines Conference in New York, NY, on October 2, 2023,
at 5:30 p.m. ET.
A webcast of the presentation may be accessed from the Investors
section of Voyager’s website at ir.voyagertherapeutics.com. A
replay of the webcast will be archived on the Company's website for
at least 30 days.
About Voyager TherapeuticsVoyager
Therapeutics (Nasdaq: VYGR) is a biotechnology company dedicated to
breaking through barriers in gene therapy and neurology. The
potential of both disciplines has been constrained by delivery
challenges; Voyager is leveraging cutting-edge expertise in capsid
discovery and deep neuropharmacology capabilities to address these
constraints. Voyager’s TRACER™ AAV capsid discovery platform has
generated novel capsids with high target delivery and blood-brain
barrier penetration at low doses, potentially addressing the narrow
therapeutic window associated with conventional gene therapy
delivery vectors. This platform is fueling alliances with Pfizer
Inc., Novartis Pharma AG, Neurocrine Biosciences, Inc., and Sangamo
Therapeutics, Inc., as well as multiple programs in Voyager’s own
pipeline. Voyager’s pipeline includes wholly owned and
collaborative preclinical programs in Alzheimer’s disease,
amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and other
diseases of the central nervous system, with a focus on validated
targets and biomarkers to enable a path to rapid potential
proof-of-biology. For more information, visit
www.voyagertherapeutics.com.
Voyager Therapeutics® is a registered trademark, and TRACER™ is
a trademark, of Voyager Therapeutics, Inc.
Contacts
InvestorsInvestors@vygr.com
MediaPeg
Rusconiprusconi@vergescientific.com
Voyager Therapeutics (NASDAQ:VYGR)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Voyager Therapeutics (NASDAQ:VYGR)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024